Brazil is currently a global leader in agricultural biotechnology, rivaling the United States in both total approved products and cultivated acreage. It is the most aggressive adopter of the “product-based” regulatory approach, having approved more than 140 genetically modified (GM) events, a single insertion or edit of a gene into a specific crop’s genome, for plants and processing and over 85 commercial-release requests for gene-edited (GE) organisms as of mid 2026. In biotechnology, an “event” refers to a unique instance of genetic modification specifically. If two different varieties of corn are developed to resist the same herbicide but use different genetic insertions, they are classified as two distinct events.
Brazil’s dominance is driven by its export-oriented economy, as the country is the world’s largest exporter of several key biotech commodities. For the 2025/2026 marketing year, Brazil accounts for approximately 66% of global soybean exports and 39% of maize (corn) exports. While nearly 100% of its soybean, corn, and cotton production is genetically engineered, the export of gene-edited crops is still in its early stages. Large-scale cultivation of GE crops currently focuses on specialty traits, such as waxy maize for industrial starch and high-fiber sugarcane. While major staples like drought-tolerant soybeans have received regulatory clearance, they are currently in the final stages of seed multiplication rather than occupying millions of exported hectares.
A significant regulatory and forestry milestone was reached in February 2026 when FuturaGene announced that CTNBio classified its gene-edited eucalyptus variety as a conventional organism under RN16. This is the first such classification for a major forestry species, and while the company is proceeding with controlled field trials rather than broad commercial cultivation, it signals a major expansion of the technology beyond annual food crops.
Animal biotechnology in Brazil is governed by the same body, CTNBio—under the 2005 Biosafety Law, but it faces a more complex regulatory path. Unlike crops, animals carry higher ethical and welfare concerns, and the Recombineticscase remains a cautionary pillar in the debate. In 2019, a gene-edited “hornless” bull project was scrapped after researchers discovered unintended bacterial DNA in the animal’s genome. This incident did not stop animal biotechnology, as evidenced by the 2025 approval of gene-edited tilapia for faster growth, but it effectively ended the “no-regulation” argument. It forced CTNBio to maintain a rigorous consultation process for animals to ensure that even “conventional-like” edits are truly free of unintended foreign genetic material before they enter the food chain.
Brazil’s ability to outpace its neighbors stems from its unique “Agricultural Triple Helix”: a powerful alignment between the multinational biotech sector, the massive domestic agribusiness lobby, and Embrapa, the state-owned research giant. By positioning itself as a “science-first” jurisdiction that mirrors the U.S. and Canadian regulatory logic rather than the EU’s precautionary approach, Brazil has become the preferred global laboratory for tropical biotechnology. As of May 2026, with dozens of products, from gene-edited eucalyptus to low-acrylamide wheat, currently under review, Brazil has established itself as the world’s primary engine for commercializing the next generation of edited life.
NGO Reaction
Brazi in NGOs have transitioned from attacking the “unnaturalness” of transgenics to a broader critique of a regulatory framework for gene edited crops and animals that they claim favors corporations. During the early 2000s, Greenpeace Brazil and other NGOs successfully branded GMOs as “Frankenfoods,” highlighting the risks of cross-species foreign DNA transfer. The 2018 adoption of Normative Resolution 16 (RN16) by CTNBio shifted the landscape, allowing gene-edited crops without foreign DNA to be classified as conventional. A broad coalition of more than 100 organizations led by the Permanent Campaign Against Pesticides and for Life condemned the rule as a technical loophole that bypassed sidestepping constitutional requirements for public participation, labeling and full biosafety review.
Over the last three years, the movement has shifted from public protest to defensive administrative challenges focused on three overlapping strategies. IDEC (Brazilian Institute for Consumer Defense) and Terra de Direitos are pursuing a legal strategy, arguing that RN16 creates a “regulatory vacuum” that violates the Consumer Defense Code by stripping citizens of their right to information and freedom of choice. The MST (Landless Workers’ Movement) and AS-PTA take an agroecological approach, targeting the “technological package,” claiming gene editing reinforces industrial monocultures and chemical dependency that threatens the seed sovereignty of small-scale farmers. Religious and rural labor groups such as the Pastoral Land Commission (CPT) and CONTAG frame the issue as a social justice struggle, asserting that closed-door evaluations prioritize multinational corporations over national food security and biodiversity.
International anti-GMO groups, including GMWatch, GRAIN, and the ETC Group, are providing technical research for domestic activists and scientific counter-narratives that can be used to challenge approvals for drought-tolerant soybeans and other gene edited crops, but have been unsuccessful. Without the presence of “foreign” genes to serve as a rhetorical catalyst, these groups find themselves increasingly isolated as the agricultural sector has embraced these tools and the public remains largely indifferent or supportive of the perceived economic benefits.
Animal biotechnology has faced targeted attacks. Terra de Direitos and Canadian-based ETC Group have described gene drives as “genetic extinction technology,” warning that edited traits could irreversibly spread into wild populations. Critics cite the Recombinetics hornless-cattle fiasco, in which an edited bull initially treated as conventional was later found to contain unintended bacterial DNA, and the Brazilian project was scrapped. While this episode did not lead to a surge in opposition to gene editing in agriculture, it strengthened activist claims that Brazil’s product-by-product approval system is too permissive and could lead to genetically-engineered animals and crops to enter the food chain undetected.
Updated: 11/05/2026
